Mito Genesis Spray120mg
Blend of NAD+, MOTS-c, 5-Amino-1MQ
Mito Genesis Spray Canada — Nasal Spray
Proprietary Blended Preparation
Mito Genesis Spray is a proprietary blended preparation supplied as a spray-format laboratory material. It is not a single defined chemical entity with an established identity in the chemical literature, and no PubChem record corresponds to this name.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Mito Genesis Spray is a proprietary blended preparation supplied as a spray-format laboratory material. It is not a single defined chemical entity with an established identity in the chemical literature, and no PubChem record corresponds to this name.
No published research examines a compound or formulation under this designation. The candidate literature available for review does not address this product, and nothing about its composition, mechanism or research use can be established from the published record.
Because Mito Genesis Spray is a product name rather than a characterised molecular entity, no mechanism of action can be described from the literature. The name references mitochondria, and "Genesis" in the indexed literature is a journal title rather than a biological descriptor, so the naming provides no reliable indication of composition or activity.
No research endpoints have been evaluated for this preparation in the published record. Any mechanistic or pharmacological description would require disclosure and independent verification of the constituent compounds, which is not available here.
The origin of Mito Genesis Spray is not documented in published scientific literature. There is no identifiable synthesis report, discovery paper, or characterisation study associated with the name.
Research into mitochondrial dynamics has developed largely through genetically encoded reporter systems, including mouse lines carrying photo-activatable mitochondrial markers and far-red fluorescent mitochondrial reporters, as well as comparable probe lines in zebrafish. That body of work describes imaging tools for observing mitochondrial behaviour and is unrelated to this preparation.
There is no research framework in which this preparation appears. The adjacent literature that exists concerns methods for visualising mitochondrial dynamics in model organisms using fluorescent and photo-activatable reporters, which is a tooling and imaging field rather than a study of any administered compound. Investigators considering work in mitochondrial biology would be relying on that reporter literature and on independently characterised reference compounds, not on this product.
2 of the 3 areas below are addressed directly by a paper cited on this page.
Addressed on this page by Pham 2012, Barrasso 2018, Mizoguchi 2016. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
Addressed on this page by Barrasso 2018. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
No paper cited on this page reports on uncharacterised, blended or preparations. This heading marks where Mito Genesis Spray is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 3 primary papers published between 2012 and 2018 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Mito Genesis Spray is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Mito Genesis Spray, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Mito Genesis Spray is commonly described online in connection with slowing ageing and extending lifespan. In the research literature the same compound is filed under mitochondrial dynamics imaging models, fluorescent reporter model organisms and uncharacterised blended preparations.
The 3 papers cited on this page, published between 2012 and 2018 (2 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
The lot code printed on the vial matches the code on the certificate for Mito Genesis Spray. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Mito Genesis Spray in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
Mito Genesis Spray ships as a prepared solution rather than as lyophilized powder, so it is already past the point at which a powder would be reconstituted. That shortens handling but tightens storage: a compound in solution is less stable than the same compound dry, and refrigeration from arrival onward is the relevant control.
The stability window for a solution is shorter than the shelf life of a sealed lyophilized vial of the same compound. Records for laboratory work in this format should note the date the unit was opened, not only the date it was received.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled fill volume. Because this is a blended preparation rather than a single defined compound, buyers should request current batch documentation before use.
The unit contains only the preparation as supplied. Any laboratory materials required for handling, dilution, or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Mouse lines with photo-activatable mitochondria to study mitochondrial dynamics
PubMedThe mito::mKate2 mouse: A far-red fluorescent reporter mouse line for tracking mitochondrial dynamics in vivo
PubMedZebrafish lines expressing UAS-driven red probes for monitoring cytoskeletal dynamics
PubMedRelated
Eppix Flash Sale −30%Peptides
Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.
RETA-CA-26F-1099.637%
11.76 mg / 10 mg
$41.96$59.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$24.46$34.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Peptides
Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$101.46$144.95CAD
Flash sale ends in
